It has been widely postulated that the central mechanism of hepatic reperfusion injury involves the conversion, during ischemia, of the enzyme xanthine dehydrogenase (XDH) to its free radical-producing form, xanthine oxidase (XOD). However, this theory has been questioned because (a) XDH to XOD conversion in whole liver occurs very slowly; (b) the cellular distribution of XDH/XOD is unclear; and (c) the direct demonstration of XDH to XOD conversion in viable cells is lacking. In this paper, we address all three issues by measuring XDH to XOD conversion and cell viability in purified populations of hepatic endothelial cells (EC), Kupffer cells (KC), and hepatocytes (HEP). Although XDH/XOD activity on a cellular basis was greater in hepatocytes (0.92 +/-0.12 mU/10(6) cells) than ECs (0.03 +/-0.01) or KCs (0.12 +/-0.04), XDH + XOD specific activity was similar in all three cell types (HEP 1.85 +/-0.10 U/g protein; EC 1.69 +/-0.54; KC 2.30 +/-0.22). Over 150 min of warm (37 degrees C) or 24 h of cold (4 degrees C) hypoxia, percent XOD activity increased slowly in ECs, from 21 +/-2% (basal) to 39 +/-3% (warm) and 49 +/-5% (cold) and in HEPs (29 +/-2% to 38 +/-3% and 49 +/-2%), but converted significantly faster in KCs (28 +/-3% to 91 […] 
Introduction
With improvements in immunosuppresive and surgical techniques over the last decade, liver transplantation has become an increasingly common and important clinical tool, with over 3,000 operations performed a year in nearly 65 centers in the United States (1) . In contrast, the procurement and optimal preservation of donor organs continues to be a major difficulty marked by a 10% rate of primary graft nonfunction with an even greater level of preservation/reperfusion injury (2) . To improve preservation techniques, a keener insight into the mechanisms of ischemic/reperfusion injury is required.
Despite a plethora of research on reperfusion injury in the heart, gut, kidney, and liver, there is little consensus on the key mechanistic elements of this process. However, most researchers agree that oxygen-derived free radicals formed during reperfusion are important elements of this injury. These radicals are believed to be involved in lipid peroxidation (3) , protein oxidation (4), and cross-linking (5) , and as signals for other injurious processes such as neutrophil chemotaxis (6) (7) (8) and concomitant microvascular blockade (9, 10) .
Perhaps the most prevalent and controversial theory regarding reperfusion injury relates to the role of xanthine oxidase (XOD)' in generating these free radicals. Xanthine dehydrogenase (XDH) is a unique enzyme in that it may undergo both a reversible conformational change, involving the oxidation of several of its 14 sulfhydryl groups, or an irreversible proteolytic cleavage to a smaller species (XODe), both with oxidase activity (1 1, 12) . Both XDH and XOD use xanthine or hypoxanthine as substrates, however XDH uses NAD+ as an electron acceptor to form NADH, whereas XOD uses molecular oxygen as an electron acceptor to form the superoxide radical.
In 1983, Roy and McCord (13) published data demonstrating the rapid conversion of XDH to XOD during warm ischemia in a number of excised tissues, including the liver. These results lay the foundation for the XOD theory of reperfusion injury. According to this hypothesis, during ischemia, endogenous, NAD+ -dependent XDH is converted to the oxygen radical-producing form, XOD. Concurrently, there is an accumulation of the reduced substrates hypoxanthine and xanthine from the breakdown of ATP during hypoxia. Upon reoxygenation, XOD reacts with molecular oxygen, the limiting reactant during ischemia, to produce a burst of superoxide radicals which mediate subsequent injurious events. Evidence supporting this role for XOD is primarily indirect, based on the observation that allopurinol, an inhibitor of XOD, is as effective as oxygen radical scavengers in diminishing ischemia/reperfusion-related tissue injury (14-16).
The importance of XOD in reperfusion injury, especially in the liver, remains controversial. The questions regarding this theory center on three major issues: (a) the conversion from 1 . Abbreviations used in this paper: EC, endothelial cell; HEP, hepatocyte; KC, Kupffer cell; XDH, xanthine dehydrogenase; XOD, xanthine oxidase; XODc, conformationally altered XOD; XODe, enzymatically cleaved XOD.
XDH to XOD appears to occur in a time course too slow to explain reperfusion events (17) (18) (19) ; (b) the cellular localization of XOD within the liver is unclear (20) ; and (c) no definitive demonstration of XDH to XOD conversion in live cells has been made yet.
If the proposed model of reperfusion injury is correct, then XDH to XOD conversion must occur in a time frame consistent with observed cellular damage. Although there is substantial enzyme conversion during hypoxia, under certain well-defined physiological conditions (starved rats with cardiopulmonary arrest; 19 ), several studies investigating XDH to XOD conversion in excised liver suggest that the rate of conversion is incompatible with the purported role of XOD in mediating reperfusion injury (17, 18) . However, in measuring whole organ activity, changes in XOD levels in the nonparenchymal cells may be missed due to the dominance of hepatocellular protein (> 90%). This problem is of particular concern since recent data now suggest that endothelial cells (ECs) and Kupffer cells (KCs) play a major role in mediating hepatic reperfusion injury (21) . In fact, the one major advance in liver preservation has been the use of the University of Wisconsin solution (UW), which acts primarily by decreasing nonparenchymal cell injury (22, 23) . Several investigators now suggest that hepatic reperfusion injury may be due to EC and/or KC free radical production (24) (25) (26) .
The potential importance of nonparenchymal cell oxyradical production raises the issue of the cellular distribution of XOD/ XDH in the liver. Histologic studies have produced conflicting data supporting either EC (27, 28) or hepatocellular localization of XOD (29) (30) (31) The supematants from the washings above were centrifuged at 500 g for 10 min, the supernatants were discarded, and the pellet was resuspended in 10 cm3 of Krebs solution. This pellet contained mostly nonparenchymal cells. These cells were counted, and their viability was assessed by trypan blue exclusion. The cells were then elutriated at a rotor speed of 2,500 rpm at 4°C. The flow rates for the isolation of the various cell types were as follows: ECs 24 cm3/min, ECs plus KCs 35 cm3/ min, KCs 46 cm3/min, and HEPs with the rotor off.
HEPs were prepared using the above procedure without the use of pronase. Since cell purity was high and viability was superior without elutriation, subsequent preparations were done by differential centrifugation alone. XOD/XDH activity was similar in viable elutriated and nonelutriated hepatocytes.
Cell purity was assessed by (a) All incubations were accompanied by gentle shaking. After the incubations were complete, the cells were spun down (50 g for 1 min for the HEPs, and 500 g for 10 min for the ECs and KCs) and transferred to a phosphate buffer (pH 7.8) containing 0.05 M potassium phosphate, 1.0 mM EDTA, 0.2 mM PMSF (to inhibit irreversible XDH to XOD conversion), and 0.5 mM DTT (to inhibit reversible XDH to XOD conversion). For cell injury studies, KCs were spun down after 16 h of cold hypoxia and then resuspended in oxygen or nitrogen (control) saturated Krebs buffer at 37°C with or without 100 pM allopurinol.
Enzyme purification. The resultant cell suspensions were sonicated (50 Sonic Dismembrator; Fisher Scientific Co., Pittsburgh, PA) and spun at 27,000 g for 30 min. The supernatant was passed through a Sephadex G-25 column (Pharmacia Fine Chemicals, Uppsala, Sweden) to remove any endogenous inhibitors or substrates and was assayed immediately.
XOD/XDH assays. The eluate was assayed for XDH and XOD activity using a micromodification of the method of Waud and Rajagopalan (19, 37) . Uric acid formation was measured spectrophotometrically at 295 nm with (XOD + XDH) or without (XOD) 1 mM NAD+ at 25°C. Percent XOD activity was expressed as the rate of formation of uric acid without NAD+ divided by the rate with NAD+.In the experiments where conformationally altered XOD activity (XODc) was mea- sured, the cells were transferred to a phosphate buffer without DTT. XODc activity was calculated as the difference in XOD activity in the same cell preparation with (XODe) and without (XODe + XODc)
DPT. Protein content was quantified using the Lowry protein determination with BSA as a standard (38) . Statistics. All assays were run in duplicate or triplicate, and data are expressed as mean±SEM. Data were analyzed using an analysis of variance followed by Fischer's least significant difference test for paired data (SYSTAT for Windows). A probability of < 0.05 was considered statistically significant.
Results
Determination of XOD + XDH cellular and specific activities in isolated HEPs, ECs, and KCs. Enzymatic activity on a cellular basis (Fig. 1) Fig. 2 , percent XOD activity increased in all three cell types at 37°C over 150 min of hypoxia. The rates of increase in the HEPs and ECs were similarly low with linear increases in percent XOD activity from initial values of 29±2 and 21±2%, respectively, to 38±3 and 39+3% XOD activity after 150 min of hypoxia. XOD activity increased much more rapidly in the KCs. Although initial percent XOD activity was similar to the other cell types (28±3% ), it was significantly higher (P < 0.05) after only 90 min of hypoxia, and after 150 min of warm hypoxia the KCs had converted to 91±7% oxidase activity, nearly double that of the other two cell types.
Similar results were found for hypoxic incubation at 4°C (Fig. 3) . HEPs Changes in specific activity. Since we have adopted the widely used convention of expressing conversion from XDH to XOD activity as XOD/XOD + XDH (13, 18, 20, 39) , the data presented above do not exclude the possibility that decreases in XDH activity alone contributed to the increase in percent XOD activity. However, as shown for KC enzyme activity during cold hypoxia, the total XOD + XDH specific activity did not change significantly throughout the duration of the experiment (Fig. 4) . XDH specific activity decreased throughout the incubation period, matched by increases in XOD specific activity. Thus the increase in percent XOD activity was due entirely to conversion from the dehydrogenase to oxidase form, not to a decrease in dehydrogenase activity.
Determination of DlT-labile activity. Since the homogenization buffer contained DTT, the results reported thus far have Duration of Hypoxia (h) Figure 4 . Changes in XOD, XDH, and XOD plus dehydrogenase specific activities during cold hypoxia in isolated KCs. KCs were isolated using countercurrent elutriation and incubated in nitrogen-saturated Krebs solution at 4°C for the specified intervals. XOD + XDH (hori-ontal bars), XOD (gray), and XDH (stippled) specific activities (U/g protein) are plotted as the mean±SE for at least three cell preparations per group.
represented only the XDH cleavage product with oxidase activity, XODe. However, the XDH molecule may undergo a conformational change to a form with oxidase activity, XODc or DTTlabile XOD (11, 12). The physiological importance of XODc is unclear but it may represent the major intermediate for cleavage to XODe (17, 19) . Since total XOD activity is the sum of both forms, XODc may also be important in oxyradical formation. Therefore, we measured the activity of this form of the enzyme in each cell type during hypoxia. Although XODc activity was negligible in all three cell types at the time of isolation (data not shown), it rose to 41±6S6% in the KCs after 90 min of hypoxic incubation at 37°C, and total XOD activity (XODc + XODe) in these cells approached 100% (Fig. 5 A) . In contrast, XODc activity in HEPs and ECs was significantly lower ( 19±6 and 7±3Y%, respectively; P < 0.01 ) after the same period of warm hypoxia. After 8 h of hypoxia at 4°C, the KC XODc rose to high levels (35±+7%), with total XOD > 80%. There was little XODc formation in either the ECs (4+5%) or HEPs (2±3%) at this time (Fig. 5 B) . Thus, conversion from XDH to XOD activity in the KCs was near completion after only 90 min of warm or 8 h of cold hypoxia. KC viability and conversion to XOD. To determine whether the conversion of XDH to XOD was occurring within live cells, cell viability, as quantified by trypan blue exclusion, was measured at each time point along with XOD/XDH activity. The conversion to high XOD activity during cold hypoxia in KCs took place with only small changes in cell viability (Fig. 6) . Similarly, after 90 min of warm hypoxia, total XOD activity (XODc + XODe) was 89+5% and KC viability was 89±3%.
Thus, near complete conversion to the oxidase form took place in KCs during warm and cold hypoxia without a marked decrease in cell viability. KC viability after 16 h of cold hypoxia (67±4% trypan blue negative, n = 4) was markedly decreased after30min(31±44%,P< 0.01)and60min(9+4%,P< 0.01) of reoxygenation at 37°C. However, the addition of 100 1M allopurinol (76+4% after 16 h cold hypoxia, n = 4) reduced this reoxygenation injury at both time points (45±4 and 29±4%, respectively; P < 0.05 versus allopurinol group) to levels similar to warm hypoxic controls (42±5 and 33± 11 I I%). 
Discussion
The XOD theory of reperfusion injury proposes that the conversion of XDH to XOD during ischemia is the underlying mechanism for subsequent free radical formation and injury during reperfusion (40 central role in the more recently advanced "no-flow" theory of reperfusion injury (9, 10 We found XOD + XDH activity on a per cell basis to be much greater in HEPs than in either ECs or KCs (Fig. 1) . This was not surprising given the much larger cell volume and protein content of these cells. However, the nonparenchymal cells and HEPs had similar XDH + XOD specific activities. Therefore, ECs and the KCs possess significant, potentially physiologically important XDH + XOD levels. This direct measurement of XOD + XDH activity in the liver contrasts with the histochemical data available (27, [29] [30] [31] ) primarily by demonstrating the potential importance of KC XOD activity, which has not been reported previously.
Since HEPs are the dominant cell type in the liver in terms of size, number, and protein content (> 90% liver protein), enzymatic changes in the nonparenchymal cells may be missed when measuring XOD activity in the whole organ. Therefore, we decided to study the time course of XDH to XOD conversion in purified populations of nonparenchymal cells and HEPs. XOD formation was relatively slow in isolated HEPs and ECs during warm hypoxia (Fig. 2) . The rate of conversion in isolated HEPs was similar to the rate we reported previously in whole liver. After 150 min of hypoxia, isolated HEPs had 38+3% XOD activity. This figure corresponds well to the 40% XOD activity we found in the entire liver after the same period of hypoxia (19) . This suggests that results from our isolated cell model may reflect changes in the intact liver, since our cell isolation procedure produced no evident increase in the rate of XOD conversion in isolated HEPs compared with that of the entire organ.
During hypoxic incubation, XOD activity rose dramatically faster in KCs than in HEPs or ECs (Fig. 2) with slower but similar rates of XOD accrual during incubation at 4°C (Fig. 3) . These surprising results suggest that KC XOD may be important in hepatic reperfusion injury and that modulation of this activity is likely missed when changes in total organ activity are measured. Several groups (17, 18, 47) , including our own (19) , have reported a much slower rate of XDH to XOD conversion in whole liver than we report here for KCs.
The conformationally altered form of the XDH molecule with oxidase activity (XODc) is formed from the oxidation of several of the 14 sulfhydryl groups of XDH (37) . This form is believed to precede cleavage to the smaller molecule, XODe (17, 19) . The present data support this theory since increases in KC XODc seemed to precede conversion to XODe. When total XOD activity (XODc + XODe) is considered, most of the enzyme in KCs was in this free radical-producing state after only 90 min of warm or 8 h of cold hypoxia. This rapid conversion rate is consistent with a role for KC XOD in mediating reperfusion injury in the liver.
Although we adopted the widely used convention of expressing XOD data in relative terms (XOD/XOD + XDH) and demonstrated rapid changes in percent XOD activity in KCs during hypoxia, it is changes in XOD specific activity that are of physiological importance. As displayed in Fig. 4 , increases in percent XOD activity in KCs during cold hypoxia did in fact represent parallel increases in XOD specific activity due to conversion from one enzyme form to the other.
If XOD mediates reperfusion injury, increases in XOD activity must occur within living cells during ischemia. We found large changes in XOD activity during cold hypoxia with little change in KC viability, as measured by trypan blue exclusion (Fig. 6) . After 90 min of warm hypoxia there was conversion to nearly 90% XOD activity (XODc + XODe) without any significant decrement in cell viability. Similar changes in HEP or EC XOD activity did not occur without large losses of cell viability (data not shown). Although we had previously demonstrated increases in XOD within viable liver tissue ( 19) , the data presented in this paper provide the first direct demonstration of large increases in XOD within live cells in the liver. Although the increases in XOD demonstrated in these studies do not appear to be due to cell death, this observation is limited by the sensitivity of the trypan blue exclusion assay and the ability to clearly define early cell mortality. However, within this limitation there are large increases in XOD activity within viable KCs during either warm or cold hypoxia. The relevance of these findings to reperfusion injury is reflected by our observation that KC death after a brief period of reoxygenation (after 16 h of cold hypoxia) is blocked by the XOD inhibitor allopurinol. These findings may also explain the observation that KCs are more susceptible to reperfusion injury than hepatocytes (48), since HEPs die an hypoxic death before accumulating large amounts of XOD. Although the nonparenchymal cells account for only a small amount of the total hepatic protein, XOD conversion in these cell types may be relevant to current theories of hepatic reperfusion injury. Based on data from the cardiac (9) as well as hepatic (49) (50) (51) and gut (52) literature it has been proposed that EC-neutrophil interactions mediate reperfusion injury. This "no-reflow" theory suggests that reperfusion injury represents long-term ischemia due to the plugging of capillaries by adherent neutrophils during reperfusion (53) . This theory still maintains a role for EC XOD as the source of free radicals (54, 55 ) that signal neutrophil chemotaxis (7, 50) and adherence to ECs (56) during reperfusion. Thus, allopurinol as well as free radical scavengers appear to inhibit neutrophil infiltration (52) . Based on this theory, we expected to find rapid changes in EC XOD during hypoxia. Instead we found more rapid changes in KC XOD activity. Since KCs also line the lumen of the hepatic sinusoids, free radicals generated by these cells may also act as chemical messengers for neutrophil chemotaxis and other signaling events.
Recent data have suggested that KC free radical generation may mediate hepatic reperfusion injury (57, 58) . KC inactivators, such as methyl palmitate, have been shown to significantly protect the liver from oxidative ischemia-reperfusion injury (59) . In our own model of cold liver preservation and reperfusion, we have found that oxyradical production is primarily a KC-mediated event (60) . The idea that KCs may mediate hepatocellular injury is not novel as there are both old (61 ) and new data (62) documenting KC/HEP interactions. Additionally, the concept of KC-derived free radicals (via XOD) acting on ECs or HEPs may help explain the large body of data on the amelioration of reperfusion injury by superoxide dismutase (63), a superoxide scavenger which does not readily enter the cell.
Since KC XOD accounts for only a small fraction of that found in the liver, one would expect that XOD-derived oxyradical production during hepatic reperfusion would be relatively modest. This inference is not inconsistent with the theory that XOD-derived oxyradicals from KCs play a major role in hepatic reperfusion injury. Recent data suggest that free radicals formed during reperfusion mediate signal transduction rather than direct oxidative injury (50, 64) . Therefore, reperfusion injury may be mediated by relatively modest increases in oxyradical production.
In summary, we have demonstrated that ECs and KCs, as well as HEPs, contain significant amounts of XOD + XDH activity. During hypoxia, there is conversion from XDH to XOD in all three cell types. However, the rate of conversion within viable KCs at either 37 or 4°C is markedly faster than that of ECs or HEPs. Furthermore, large increases in XOD specific activity occur within viable KCs, and cell death accompanying the reoxygenation of such cells is blocked by the XOD inhibitor allopurinol. This is the first direct evidence that significant conversion to XOD activity can occur in living cells in the liver within the time constraints of observed ischemia-reperfusion injury. These data may explain the discrepancy between the effects of the XOD inhibitor allopurinol in ameliorating reperfusion injury and the relatively slow rates of XDH to XOD conversion reported in the (whole) liver. Further studies directed toward understanding the modulation of KC XOD activity and the physiologic effects of oxyradicals generated by the KCs during reperfusion should aid in further defining the mechanism(s) of hepatic reperfusion injury.
